Clinical Trials on HR+ Metastatic Breast Cancer
Total 16082 results
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
National Cancer Institute (NCI)RecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Metastatic HER2-Negative Breast CarcinomaUnited States
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyRecruitingMetastatic Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerAustria, Belgium, Italy, Spain, France, Switzerland, Denmark, Norway, Sweden
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Sindh Institute of Urology and TransplantationCompletedBreast Cancer | Breast Neoplasms | Breast Cancer Metastatic | Breast Cancer Stage | Breast Cancer InvasivePakistan
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
Carrick Therapeutics LimitedPfizerRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerSpain, United States, Turkey, Hungary
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
SCRI Development Innovations, LLCDaiichi Sankyo, Inc.RecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerUnited States
-
Consorzio OncotechRecruitingMetastatic Breast Cancer | Locally Advanced Breast CancerItaly
-
Rhizen Pharmaceuticals SACompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGeorgia
-
University of RochesterJohns Hopkins UniversityCompletedMetastatic Breast Cancer | Breast Cancer Stage IVUnited States
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Meabco A/SMeddoc; Norwegian University of Life SciencesCompletedMetastatic Breast Cancer | Stage IV Breast CancerThailand, Russian Federation
-
Heidelberg UniversityDafra Pharma; Hector-Stiftung; Monika-Kutzner Stiftung, Berlin, Germany; HEIFAN-Heidelberger...CompletedMetastatic Breast Cancer | Locally Advanced Breast CancerGermany
-
Cairo UniversityUnknownBreast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast CancerEgypt
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Leptomeningeal Metastases | Recurrent Breast Cancer | Central Nervous System Metastases | Tumors Metastatic to BrainUnited States
-
Cancer Trials IrelandTerminatedMetastatic Breast Cancer | HER2-positive Breast Cancer | Locally Advanced Breast Cancer | Unresectable Breast CancerIreland, Spain
-
MedSIRHoffmann-La RocheCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerSpain, France, United Kingdom, Germany, Italy
-
Carrick Therapeutics LimitedBerlin-Chemie AG Menarini GroupRecruitingBreast Cancer | Metastatic Breast Cancer | Locally Advanced Breast CancerUnited States, France, Spain, United Kingdom
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Hoffmann-La RocheActive, not recruitingMetastatic Breast Cancer | Locally Advanced Breast CancerGreece, Cyprus
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Meabco A/SMeddoc; Norwegian University of Life Sciences; Meddoc Research Indonesia Ltd; Meddoc...CompletedMetastatic Breast Cancer | Stage IV Breast CancerTaiwan, Thailand, Indonesia
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Zhejiang Cancer HospitalNot yet recruiting
-
Mary D ChamberlinDartmouth-Hitchcock Medical CenterNot yet recruitingMetastatic Breast Cancer
-
National Taiwan University HospitalAstraZenecaRecruiting
-
ZionexaGE Healthcare; Simbec-Orion Group; KeosysRecruitingMetastatic Breast CancerFrance
-
Jiangsu Tasly Diyi Pharmaceutical Co., Ltd.Not yet recruitingBreast Cancer MetastaticChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingMetastatic Breast CancerChina
-
University of LouisvilleJames Graham Brown Cancer CenterRecruitingMetastatic Breast CancerUnited States
-
Gustave Roussy, Cancer Campus, Grand ParisDaiichi Sankyo, Inc.RecruitingMetastatic Breast CancerFrance
-
PfizerRecruitingMetastatic Breast CancerLebanon, Jordan, Qatar, Egypt, Saudi Arabia
-
Samsung Medical CenterRecruitingMetastatic Breast CancerKorea, Republic of
-
SOLTI Breast Cancer Research GroupRoche Pharma AGRecruitingMetastatic Breast CancerSpain
-
Shandong Cancer Hospital and InstituteNot yet recruiting
-
Shandong Cancer Hospital and InstituteNot yet recruitingMetastatic Breast Cancer
-
Minerva Biotechnologies CorporationCity of Hope Medical CenterRecruitingMetastatic Breast CancerUnited States
-
Medical College of WisconsinLoyola University ChicagoRecruitingMetastatic Breast CancerUnited States
-
University Medical Center GroningenCompletedMetastatic Breast CancerNetherlands
-
PfizerCompletedMetastatic Breast CancerSpain, Belgium, Sweden, United Kingdom, Austria, Germany, Switzerland
-
European Institute of OncologyActive, not recruitingMetastatic Breast CancerItaly
-
ETOP IBCSG Partners FoundationBreast International GroupCompletedPalbociclib in Molecularly Characterized ER-positive/HER2-negative Metastatic Breast Cancer (PYTHIA)Metastatic Breast CancerUnited Kingdom, Belgium, Italy
-
UNICANCERAstraZeneca; Fondation ARCActive, not recruiting
-
Spanish Breast Cancer Research GroupActive, not recruitingMetastatic Breast CancerSpain
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Bayer; Novartis Pharmaceuticals; Rutgers Cancer...CompletedMetastatic Breast CancerUnited States